Home  |  Contact

UniProtKB/Swiss-Prot P37058: Variant p.Gly133Arg

17-beta-hydroxysteroid dehydrogenase type 3
Gene: HSD17B3
Variant information

Variant position:  133
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Arginine (R) at position 133 (G133R, p.Gly133Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MPH; almost complete loss of testosterone 17-beta-dehydrogenase (NADP(+)) activity; no effect on protein abundance; no effect on endoplasmic reticulum location.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  133
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  310
The length of the canonical sequence.

Location on the sequence:   YEHIKEKLAGLEIGILVNNV  G MLPNLLPSHFLNAPDEIQSL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YEHIKEKLAGLEIGILVNNVGMLPNLLPSHFLNAPD---EIQSL

Mouse                         YDHIKEHLEGLEIGILVNNVGMLPSFFPSHFLSTSG---ES

Rat                           YDHIEEQLKGLEIGVLVNNVGMLPNLLPSHFLSTSG---ES

Zebrafish                     YGHITENIEGLDIGVLVNNVGILPSQIPCKLLETSDLEERI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 310 17-beta-hydroxysteroid dehydrogenase type 3
Mutagenesis 133 – 133 G -> A. Has 70% of wild-type testosterone 17-beta-dehydrogenase (NADP(+)) activity.
Mutagenesis 133 – 133 G -> F. Almost complete loss of testosterone 17-beta-dehydrogenase (NADP(+)) activity.
Mutagenesis 133 – 133 G -> Q. Almost complete loss of testosterone 17-beta-dehydrogenase (NADP(+)) activity.


Literature citations

Biochemical analyses and molecular modeling explain the functional loss of 17beta-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development.
Engeli R.T.; Rhouma B.B.; Sager C.P.; Tsachaki M.; Birk J.; Fakhfakh F.; Keskes L.; Belguith N.; Odermatt A.;
J. Steroid Biochem. Mol. Biol. 155:147-154(2016)
Cited for: VARIANT MPH ARG-133; CHARACTERIZATION OF VARIANT MPH ARG-133; FUNCTION; CATALYTIC ACTIVITY; SUBCELLULAR LOCATION; MUTAGENESIS OF GLY-133;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.